1,135
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Pharmacokinetic study on the interaction between succinic acid and irbesartan in rats and its potential mechanism

, , &
Pages 1617-1620 | Received 12 Jul 2021, Accepted 29 Oct 2021, Published online: 24 Nov 2021

References

  • Amadi CN, Mgbahurike AA. 2018. Selected food/herb-drug interactions: mechanisms and clinical relevance. Am J Ther. 25(4):e423–e433.
  • Bourrie M, Meunier V, Berger Y, Fabre G. 1999. Role of cytochrome P-4502C9 in irbesartan oxidation by human liver microsomes. Drug Metab Dispos. 27(2):288–296.
  • Elgawish MS, Soltan MK, Sebaiy MM. 2019. An LC-MS/MS spectrometry method for the simultaneous determination of rosuvastatin and irbesartan in rat plasma: Insight into pharmacokinetic and drug-drug interaction studies. J Pharm Biomed Anal. 174:226–234.
  • Fabbri C, Serretti A. 2020. Genetics of treatment outcomes in major depressive disorder: present and future. Clin Psychopharmacol Neurosci. 18(1):1–9.
  • Hedaya MA, Helmy SA. 2015. Modeling of the pharmacokinetic/pharmacodynamic interaction between irbesartan and hydrochlorothiazide in normotensive subjects. Biopharm Drug Dispos. 36(4):216–231.
  • Jakobsdottir G, Xu J, Molin G, Ahrne S, Nyman M. 2013. High-fat diet reduces the formation of butyrate, but increases succinate, inflammation, liver fat and cholesterol in rats, while dietary fibre counteracts these effects. PLOS One. 8(11):e80476.
  • Liu J, Zhang N, Li N, Fan X, Li Y. 2019. Influence of verapamil on the pharmacokinetics of oridonin in rats. Pharm Biol. 57(1):787–791.
  • Magliocco G, Thomas A, Desmeules J, Daali Y. 2019. Phenotyping of human CYP450 enzymes by endobiotics: current knowledge and methodological approaches. Clin Pharmacokinet. 58(11):1373–1391.
  • Malishevskii MV. 2012. Irbesartan in clinical practice. Kardiologiia. 52:66–74.
  • Marino MR, Vachharajani NN. 2001. Drug interactions with irbesartan. Clin Pharmacokinet. 40(8):605–614.
  • Markham A, Spencer CM, Jarvis B. 2000. Irbesartan: an updated review of its use in cardiovascular disorders. Drugs. 59(5):1187–1206.
  • Nissen MD, Lau ETL, Cabot PJ, Steadman KJ. 2019. Baltic amber teething necklaces: could succinic acid leaching from beads provide anti-inflammatory effects? BMC Complement Altern Med. 19(1):162–170.
  • Parvez MK, Rishi V. 2019. Herb-drug interactions and hepatotoxicity. Curr Drug Metab. 20(4):275–282.
  • Rekić D, Reynolds KS, Zhao P, Zhang L, Yoshida K, Sachar M, Piquette Miller M, Huang SM, Zineh I. 2017. Clinical drug-drug interaction evaluations to inform drug use and enable drug access. J Pharm Sci. 106(9):2214–2218.
  • Tang XL, Liu JX, Li P, Dong W, Li L, Zheng YQ, Hou JC. 2013. Protective effect of succinic acid on primary cardiomyocyte hypoxia/reoxygenation injury. Zhongguo Zhong Yao Za Zhi. 38:3742–3746.
  • Vignier N, Le Corvoisier P, Blard C, Sambin L, Azibani F, Schlossarek S, Delcayre C, Carrier L, Hittinger L, Su JB. 2014. AT1 blockade abolishes left ventricular hypertrophy in heterozygous cMyBP-C null mice: role of FHL1. Fundam Clin Pharmacol. 28(3):249–256.
  • Wang H, Xia B, Lin M, Wang Y, Sun B, Li Y. 2020. Succinic acid inhibits the activity of cytochrome P450 (CYP450) enzymes. Pharm Biol. 58(1):1150–1155.
  • Yang R, Luo Z, Liu Y, Sun M, Zheng L, Chen Y, Li Y, Wang H, Chen L, Wu M, et al. 2016. Drug interactions with angiotensin receptor blockers: role of human cytochromes P450. Curr Drug Metab. 17(7):681–691.
  • Zhang QC, Zhao Y, Bian HM. 2014. Anti-thrombotic effect of a novel formula from Corni fructus with malic acid, succinic acid and citric acid. Phytother Res. 28(5):722–727.
  • Zhang X, Zhang X, Wang X, Zhao M. 2018. Influence of andrographolide on the pharmacokinetics of warfarin in rats. Pharm Biol. 56(1):351–356.
  • Zhou H, Li W, Sun L, Li W, Liu Q. 2021. A rapid LC-MS/MS method for simultaneous determination of berberine and irbesartan in rat plasma: application to the drug-drug pharmacokinetic interaction study after oral administration in rats. Biomed Chromatogr. 35(9):e5144.